{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihi5lmce3njtbxm7rizimujp52gbh3ovmxfzs223ppcio225l42ue",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mgl5yp66d4s2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidejfwognityu6yygyzgf2bvpuieq4dxcyhxugtqdmow7wybv23yu"
    },
    "mimeType": "image/jpeg",
    "size": 258354
  },
  "path": "/news/2026-03-earlier-asthma-biologics-children-severe.html",
  "publishedAt": "2026-03-08T16:10:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly across different ages and early-life risk profiles. This evidence gap constrains precision in treatment decisions and clinical guidance.",
  "title": "Study finds earlier asthma biologics in children cut severe attacks most"
}